Prostate Cancer Spurs New Nerves Science Daily (press release) - "We also believe that axongenesis and neurogenesis is found not only in prostate cancer, but is potentially a more global phenomenon, particularly relating ...
Health Buzz: World AIDS Day and Other Health News U.S. News & World Report, DC - 49 minutes ago Last year, US News explained how robotic surgery and other newer technologies are tackling early-stage prostate cancer. This September, Nancy Shute ...
Raised hopes for prostate cancer sufferers Times Online, UK - Not everyone's general health makes them suitable for radical treatment and some patients may have tumours too advanced for the cancer to be eradicated. ...
Radiotherapy Safe for Prostate Cancer in HIV-Infected Patients Cancerpage.com, GA - 57 minutes ago NEW YORK DEC 01, 2008 (Reuters Health) - The results of small study suggest that radiotherapy can be safely used to treat prostate cancer in HIV-infected ...
108 holes not a bad round! Sunshine Coast Daily, Australia - In doing so, he raised more than $6000 for prostate cancer research. Shortly after closing out his sixth round of the day, Matt said he felt he had more ...
Date set for cancer services transfer RTE.ie, Ireland - ... Professor Tom Keane said that after the breast cancer organisation, he would focus on prostate and lung cancer service reform. He said he was not fond ...
Source: Google News
Recent News and Articles on the Keywords: prostate cancer + prostate + cancer Related to the article below (Last Update: 8/7/2008)
Prostate Cancer Canada.com, Canada - Prostate cancer is the cancer most often diagnosed in Canadian men. It is second only to lung cancer as a cause of cancer death in Canadian men aged 65 and ...
Palace denies Prince Philip has prostate cancer AFP - The Evening Standard quoted an unnamed cancer specialist as saying: "It's become an open secret within the medical community that Philip has prostate cancer...
Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study. - JM Chan, MJ Stampfer, E Giovannucci, PH Gann, J Ma … - The Journal of Urology, 1998 - jurology.com ... Plasma Insulin-Like Growth Factor-I and ProstateCancer Risk: A Prospective Study. ...
Citing Articles TOP. Obesity and prostatecancer. Current Opinion in Urology. ...
The Influence of Finasteride on the Development of Prostate Cancer - IM Thompson, PJ Goodman, CM Tangen, MS Lucia, GJ … - New England Journal of Medicine, 2003 - content.nejm.org The Influence of Finasteride on the Development of ProstateCancer. Ian M. Thompson,
MD, Phyllis J. Goodman, MS, Catherine M. Tangen, Dr.PH, M. Scott Lucia, MD ...
Intake of Carotenoids and Retino in Relation to Risk of Prostate Cancer - E Giovannucci, A Ascherio, EB Rimm, MJ Stampfer, … - jnci, 1995 - jnci.oxfordjournals.org ... Intake of Carotenoids and Retino in Relation to Risk of ProstateCancer. ... No consistent
association was observed for dietary retinol and risk of prostatecancer. ...
Quality-of-life outcomes in men treated for localized prostate cancer - MS Litwin, RD Hays, A Fink, PA Ganz, B Leake, GE … - JAMA, 1995 - Am Med Assoc ... Quality-of-life outcomes in men treated for localized prostatecancer. ... ABSTRACT |
FULL TEXT. Natural History of Early, Localized ProstateCancer Johansson et al. ...
Source: Google Scholar
Screening for prostate cancer may not necessarily prolong survival
Screening men for prostate cancer may not reduce their risk for dying.
More men will have been diagnosed with prostate cancer than any other cancer in 2005 and more than 30,000 men will have died from the disease.
Men can be screened for prostate cancer by measuring prostate-specific antigen ( PSA ) levels in the blood and performing digital rectal examination. However, there is little evidence of these tests' effectiveness in reducing death.
In this context, medical groups differ on screening guidelines; for instance, the American Cancer Society states that doctors should offer the PSA blood test and digital rectal exam annually to men age 50 years or older, whereas the U.S. Preventive Services Task Force has found insufficient evidence to recommend screening and the American College of Physicians advises physicians to counsel men about its benefits and risks.
John Concato, from the Veterans Affairs ( VA ) Connecticut Healthcare System, West Haven, and Yale University, New Haven, and colleagues conducted a study to address the question of whether screening improves the chances of survival.
From approximately 72,000 veterans receiving health care at any of 10 VA medical centers in New England, they identified 501 men age 50 years and older who were diagnosed with prostate cancer between 1991 and 1995 and had died by the end of 1999.
A comparison group of 501 living men was also identified; each man in this control group was matched, for age and treatment at the same center, to a man with prostate cancer who had died. Medical records were reviewed to determine whether men in either group had been screened for prostate cancer.
Seventy ( 14 percent ) of the men who died of prostate cancer and 65 ( 13 percent ) of the men in the control group were screened with PSA.
If prostate cancer screening prevented death, fewer men who died would have received screening compared to the men who were living.
In addition, screening was not found to reduce mortality among men who were younger or healthier or when digital rectal exams were also considered.
According to the authors, screening tests can increase the detection of cancer, even at earlier stages, but not necessarily prolong survival.
" Optimal clinical strategies for diagnosing and treating prostate cancer remain uncertain and in need of additional investigation," they write. " Based on available evidence, including the present study, recommendations regarding screening for prostate cancer should not endorse routine testing of asymptomatic men to reduce mortality. Rather, the uncertainty of screening should be explained to patients in a process of 'verbal informed consent,' promoting informed decision making."
The study is published in Archives of Internal Medicine.